Response to: Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations

類似資料

• Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
  著者:: Masuda, Tomomi, 等
  出版事項: (2020)
• Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
  著者:: Russano, Marco, 等
  出版事項: (2020)
• The Effectiveness of Afatinib in a Patient with Advanced Lung Adenocarcinoma Harboring Rare G719X and S768I Mutations
  著者:: Watanabe, Masahiro, 等
  出版事項: (2017)
• Cabozantinib and apixaban: an hitherto unreported interaction
  著者:: Santini, Daniele, 等
  出版事項: (2019)
• Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
  著者:: Tonini, Giuseppe, 等
  出版事項: (2013)